2nd Annual Glioblastoma Drug Development Summit
December 9, 2020 at 10:50 AM EST
Title: MDNA55, an IL4-Guided Toxin in Recurrent GBM: Phase 2b Results & Use of an External Control Arm in a Registration Trial
Session Name: Immuno-oncology & Therapy
Session Name: Immuno-oncology & Therapy